Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

Brian Lian Biography and Net Worth

CEO of Viking Therapeutics

Dr. Lian serves as our President and Chief Executive Officer, and as a director. Prior to founding Viking Therapeutics, he was a Managing Director and Senior Research Analyst at SunTrust Robinson Humphrey, where he was responsible for coverage of small and mid-cap biotechnology companies with an emphasis on the diabetes, oncology, infectious disease, and neurology spaces. Prior to SunTrust Robinson Humphrey, he was an Executive Director and Senior Biotechnology Analyst at CIBC World Markets, responsible for coverage of mid and small-cap biopharmaceutical companies. Prior to his career in equity research, he was a research scientist in small molecule drug discovery at Amgen, focused on cancer and endocrine diseases. Prior to Amgen, he was a research scientist at Microcide Pharmaceuticals. Dr. Lian holds an MBA in accounting and finance from Indiana University, an M.S. and Ph.D. in organic chemistry from The University of Michigan, and a BA in chemistry from Whitman College.

What is Brian Lian's net worth?: The estimated net worth of Brian Lian is at least $118.77 million as of September 20th, 2024. Dr. Lian owns 2,304,927 shares of Viking Therapeutics stock worth more than $118,772,888 as of November 21st. This net worth evaluation does not reflect any other assets that Dr. Lian may own. Additionally, Dr. Lian receives an annual salary of $987,100.00 as CEO at Viking Therapeutics. Learn More about Brian Lian's net worth.
How old is Brian Lian?: Dr. Lian is currently 58 years old. There are 3 older executives and no younger executives at Viking Therapeutics. Learn More on Brian Lian's age.
What is Brian Lian's salary?: As the CEO of Viking Therapeutics, Inc., Dr. Lian earns $987,100.00 per year. Learn More on Brian Lian's salary.
How do I contact Brian Lian?: The corporate mailing address for Dr. Lian and other Viking Therapeutics executives is 12340 EL CAMINO REAL SUITE 250, SAN DIEGO CA, 92130. Viking Therapeutics can also be reached via phone at (858) 704-4660 and via email at [email protected]. Learn More on Brian Lian's contact information.
Has Brian Lian been buying or selling shares of Viking Therapeutics?: Brian Lian has not been actively trading shares of Viking Therapeutics over the course of the past ninety days. Most recently, Brian Lian sold 216,130 shares of the business's stock in a transaction on Friday, September 20th. The shares were sold at an average price of $70.83, for a transaction totalling $15,308,487.90. Following the completion of the sale, the chief executive officer now directly owns 2,304,927 shares of the company's stock, valued at $163,257,979.41. Learn More on Brian Lian's trading history.
Who are Viking Therapeutics' active insiders?: Viking Therapeutics' insider roster includes Matthew Foehr (Director), Brian Lian (CEO), Lawson Macartney (Director), Marianna Mancini (COO), Sarah Rouan (Director), Charles Rowland, Jr. (Director), J. Matthew Singleton (Director), and Greg Zante (CFO). Learn More on Viking Therapeutics' active insiders.
Are insiders buying or selling shares of Viking Therapeutics?: In the last year, insiders at the biotechnology company sold shares 19 times. They sold a total of 1,383,618 shares worth more than $81,779,033.02. The most recent insider tranaction occured on November, 8th when Director Lawson Macartney sold 2,000 shares worth more than $137,340.00. Insiders at Viking Therapeutics own 4.7% of the company. Learn More about insider trades at Viking Therapeutics.
Information on this page was last updated on 11/8/2024.

Brian Lian Insider Trading History at Viking Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/20/2024	Sell	216,130	$70.83	$15,308,487.90	2,304,927
8/21/2024	Sell	1,000	$69.90	$69,900.00	2,354,927
8/19/2024	Sell	112,870	$65.80	$7,426,846.00	2,354,927
7/30/2024	Sell	115,859	$57.58	$6,671,161.22	2,354,927
2/8/2024	Sell	269,079	$26.87	$7,230,152.73	2,184,882
1/30/2024	Sell	35,000	$23.95	$838,250.00	2,264,882
5/1/2023	Sell	45,000	$22.45	$1,010,250.00	2,197,963
4/19/2023	Sell	35,000	$21.45	$750,750.00	2,242,963
4/17/2023	Sell	155,000	$20.45	$3,169,750.00	2,277,963
4/13/2023	Sell	79,336	$18.45	$1,463,749.20	2,307,963
4/3/2023	Sell	22,000	$17.85	$392,700.00	2,232,963
3/31/2023	Sell	67,970	$17.45	$1,186,076.50	2,254,963

Brian Lian Buying and Selling Activity at Viking Therapeutics

Viking Therapeutics Company Overview

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Today's Range

Now: $51.53

$50.40

$53.04

50 Day Range

MA: $64.24

$49.11

$78.03

2 Week Range

Now: $51.53

$11.21

$99.41

Volume

3,496,787 shs

Average Volume

7,145,199 shs

Market Capitalization

$5.74 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Get Your Free Gold Guide

Brian Lian Biography and Net Worth

What is Brian Lian's net worth?

How old is Brian Lian?

What is Brian Lian's salary?

How do I contact Brian Lian?

Has Brian Lian been buying or selling shares of Viking Therapeutics?

Who are Viking Therapeutics' active insiders?

Are insiders buying or selling shares of Viking Therapeutics?